Regulation of Cardiac Signaling by Class I Histone Deacetylases
I 类组蛋白脱乙酰酶对心脏信号传导的调节
基本信息
- 批准号:10219331
- 负责人:
- 金额:$ 38.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-08 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAdultAmericanCardiacCardiac MyocytesCellsClinical TrialsDataDeacetylationDevelopmentDiagnosisDiastolic heart failureEFRACEconomic BurdenEnzymesEpigenetic ProcessFDA approvedFamilyFoundationsFunctional disorderGene ExpressionGene Expression RegulationGenetic TranscriptionHDAC2 geneHealthHealthcare SystemsHeartHeart ResearchHeart failureHistone DeacetylaseHistone Deacetylase InhibitorHistonesHumanHypertensionImpairmentIndividualInvestigationLongevityMass Spectrum AnalysisMechanicsMediatingMedicalModelingMolecularMusMuscle CellsMyocardial dysfunctionMyofibrilsPathogenesisPatientsPharmaceutical PreparationsPharmacotherapyProtein AcetylationProtein IsoformsProteinsQuality of lifeRegulationRegulator GenesRelaxationReportingResearchResistanceRisk FactorsRodent ModelRoleSignal TransductionSumoylation PathwaySymptomsSystemSystemic hypertensionSystolic heart failureTailTestingTroponin IUnited Statesbasecare costscostdesignheart functionhistone acetyltransferasehospitalization ratesimprovedin vivoinnovationinterestmouse modelnon-genomicnovelnovel therapeuticspreservationpreventsmall moleculestandard of care
项目摘要
Project Summary/Abstract
It is estimated that half of the ~5 million patients in the United States who suffer from heart failure (HF) have
HF with preserved ejection fraction (HFpEF), which is also referred to as diastolic heart failure. Hypertension
is a major risk factor for the development of HFpEF. Unfortunately, large clinical trials have revealed that
standard-of-care HF medications fail to reduce hospitalization rates or improve lifespan in patients with HFpEF.
Thus, HFpEF remains a major unmet medical need. Our group has a longstanding interest in elucidating the
cardiac functions of a family of enzymes known as histone deacetylases (HDACs), which serve crucial roles as
epigenetic regulators of gene expression. Our preliminary data demonstrate remarkable ability of a small
molecule HDAC inhibitor to prevent and reverse diastolic cardiac dysfunction in rodent models of systemic
hypertension. Surprisingly, HDAC inhibition appears to improve diastolic function of the heart by enhancing
relaxation of the contractile units (myofibrils), revealing a non-canonical, non-epigenetic function for HDACs in
the control of cardiac relaxation. Three independent specific aims are designed to significantly extend this new
field of cardiac research, and test the overall hypothesis that non-genomic actions of HDACs govern
relaxation of the heart, and are critically involved in the pathogenesis of HFpEF.
项目摘要/摘要
据估计,在美国约500万心力衰竭(HF)患者中,有一半患有
射血分数保留的心衰,也称为舒张性心力衰竭。高血压
是HFpEF发生的主要危险因素。不幸的是,大型临床试验显示
标准护理HF药物未能降低HFpEF患者的住院率或延长患者的寿命。
因此,HFpEF仍然是一个主要的未得到满足的医疗需求。我们小组长期以来一直有兴趣澄清
被称为组蛋白脱乙酰酶(HDAC)的一系列酶的心脏功能,这些酶起着关键作用,如
基因表达的表观遗传调节器。我们的初步数据显示,一个小的
分子HDAC抑制剂预防和逆转系统性红斑狼疮动物模型舒张性心功能不全
高血压。令人惊讶的是,抑制HDAC似乎通过增强心脏的舒张性功能来改善心脏的舒张功能
收缩单位(肌原纤维)的松弛,揭示了HDAC的非规范、非表观遗传功能
心脏松弛的控制。三个独立的具体目标旨在显著扩展这一新的
心脏研究领域,并检验HDAC非基因组行为支配的总体假设
心脏松弛,并在HFpEF的发病机制中起关键作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.
- DOI:10.1091/mbc.e13-08-0444
- 发表时间:2013-12
- 期刊:
- 影响因子:3.3
- 作者:Pedram A;Razandi M;Narayanan R;Dalton JT;McKinsey TA;Levin ER
- 通讯作者:Levin ER
AKT network of genes and impaired myocardial contractility during murine acute Chagasic myocarditis.
小鼠急性恰加斯心肌炎期间基因 AKT 网络与心肌收缩力受损。
- DOI:10.4269/ajtmh.14-0433
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Henao-Martínez,AndrésF;Agler,AnneHermetet;Watson,AlanM;Hennessy,Corinne;Davidson,Elizabeth;Demos-Davies,Kim;McKinsey,TimothyA;Wilson,Michael;Schwartz,DavidA;Yang,IvanaV
- 通讯作者:Yang,IvanaV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy McKinsey其他文献
Timothy McKinsey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy McKinsey', 18)}}的其他基金
Advanced Small Animal Ultrasound Imaging - Vevo F2
先进的小动物超声成像 - Vevo F2
- 批准号:
10632878 - 财政年份:2023
- 资助金额:
$ 38.58万 - 项目类别:
Small molecule therapies targeting chromatin architecture in heart failure
针对心力衰竭染色质结构的小分子疗法
- 批准号:
10312765 - 财政年份:2019
- 资助金额:
$ 38.58万 - 项目类别:
Small molecule therapies targeting chromatin architecture in heart failure
针对心力衰竭染色质结构的小分子疗法
- 批准号:
10534162 - 财政年份:2019
- 资助金额:
$ 38.58万 - 项目类别:
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.
BRD4 溴结构域蛋白对心力衰竭中染色质信号传导的调节。
- 批准号:
10219336 - 财政年份:2015
- 资助金额:
$ 38.58万 - 项目类别:
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.
BRD4 溴结构域蛋白对心力衰竭中染色质信号传导的调节。
- 批准号:
10434776 - 财政年份:2015
- 资助金额:
$ 38.58万 - 项目类别:
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.
BRD4 溴结构域蛋白对心力衰竭中染色质信号传导的调节。
- 批准号:
9975206 - 财政年份:2015
- 资助金额:
$ 38.58万 - 项目类别:
Regulation of Cardiac Signaling by Class I Histone Deacetylases
I 类组蛋白脱乙酰酶对心脏信号传导的调节
- 批准号:
8577925 - 财政年份:2013
- 资助金额:
$ 38.58万 - 项目类别:
Regulation of Cardiac Signaling by Class I Histone Deacetylases
I 类组蛋白脱乙酰酶对心脏信号传导的调节
- 批准号:
8716810 - 财政年份:2013
- 资助金额:
$ 38.58万 - 项目类别:
Isoform-Selective HDAC Inhibitors for Age-Associated Diastolic Dysfunction
异构体选择性 HDAC 抑制剂治疗年龄相关舒张功能障碍
- 批准号:
8548228 - 财政年份:2012
- 资助金额:
$ 38.58万 - 项目类别:
Isoform-Selective HDAC Inhibitors for Age-Associated Diastolic Dysfunction
异构体选择性 HDAC 抑制剂治疗年龄相关舒张功能障碍
- 批准号:
8430402 - 财政年份:2012
- 资助金额:
$ 38.58万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.58万 - 项目类别:
Research Grant